Emerging Strategies for Neonatal Infections

Monday, December 3, 2012
2:00 pm – 4:00 pm

Planned in cooperation with the Pediatric Pharmacy Advocacy Group
Activity #: 204-000-12-295-L01P
Level of Content: Advanced
2.00 Contact Hours / Application-based
Program Chair: Sherry A. Luedtke, PharmD

Learning Objectives:

• Optimize the antibiotic regimen for a premature infant diagnosed with sepsis.
• Describe how to utilize biological markers to identify neonates with sepsis.
• Recommend the appropriate use of granulocyte colony-stimulating factor and intravenous immune globulin in the management of neonatal infections.
• Identify a neonate with disseminated intravascular coagulation and evaluate the role of antithrombin III.
• Define hypotension in the preterm infant and recommend management.